BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,635,346 | -20.8% | 69,829 | -4.4% | 0.43% | -16.0% |
| Q2 2023 | $3,326,700 | +129697.1% | 73,018 | +15.6% | 0.51% | +28.6% |
| Q1 2023 | $2,563 | +84.9% | 63,184 | +132.4% | 0.40% | +80.5% |
| Q4 2022 | $1,386 | -100.0% | 27,184 | -59.3% | 0.22% | -64.9% |
| Q3 2022 | $3,594,000 | -14.0% | 66,734 | +2.5% | 0.63% | -6.3% |
| Q2 2022 | $4,180,000 | +117.4% | 65,077 | +162.4% | 0.67% | +152.3% |
| Q1 2022 | $1,923,000 | -10.1% | 24,799 | -0.5% | 0.27% | -9.5% |
| Q4 2021 | $2,140,000 | +22.8% | 24,927 | +15.0% | 0.29% | +24.1% |
| Q3 2021 | $1,743,000 | +48.2% | 21,677 | +48.4% | 0.24% | +54.9% |
| Q2 2021 | $1,176,000 | -6.8% | 14,610 | -2.4% | 0.15% | -9.5% |
| Q1 2021 | $1,262,000 | +3.7% | 14,967 | -1.3% | 0.17% | -10.6% |
| Q4 2020 | $1,217,000 | -2.8% | 15,167 | -2.6% | 0.19% | -27.0% |
| Q3 2020 | $1,252,000 | -8.3% | 15,565 | -1.9% | 0.26% | -22.2% |
| Q2 2020 | $1,366,000 | +6.1% | 15,865 | 0.0% | 0.33% | -2.6% |
| Q1 2020 | $1,288,000 | -25.7% | 15,865 | -23.5% | 0.34% | +14.8% |
| Q4 2019 | $1,733,000 | -8.2% | 20,726 | -3.9% | 0.30% | -13.1% |
| Q3 2019 | $1,887,000 | -58.4% | 21,576 | -61.1% | 0.34% | -57.0% |
| Q2 2019 | $4,539,000 | +0.2% | 55,426 | -0.5% | 0.80% | -2.7% |
| Q1 2019 | $4,531,000 | +21.8% | 55,726 | -1.4% | 0.82% | +9.2% |
| Q4 2018 | $3,721,000 | -16.5% | 56,534 | -2.1% | 0.75% | -7.3% |
| Q3 2018 | $4,454,000 | +4.0% | 57,771 | -0.3% | 0.81% | 0.0% |
| Q2 2018 | $4,281,000 | +7.4% | 57,971 | -5.4% | 0.81% | +5.1% |
| Q1 2018 | $3,986,000 | -19.5% | 61,293 | -20.0% | 0.77% | -21.9% |
| Q4 2017 | $4,950,000 | -20.3% | 76,577 | -22.7% | 0.99% | -18.5% |
| Q3 2017 | $6,213,000 | +2.7% | 99,008 | -0.9% | 1.21% | +0.8% |
| Q2 2017 | $6,051,000 | +15.5% | 99,956 | -1.1% | 1.20% | +10.9% |
| Q1 2017 | $5,239,000 | +14.0% | 101,023 | -2.5% | 1.08% | +12.5% |
| Q4 2016 | $4,596,000 | +174.2% | 103,646 | +194.3% | 0.96% | +179.1% |
| Q3 2016 | $1,676,000 | +234.5% | 35,219 | +218.0% | 0.34% | +235.0% |
| Q2 2016 | $501,000 | +1.6% | 11,074 | -7.8% | 0.10% | -11.2% |
| Q1 2016 | $493,000 | +0.6% | 12,006 | -6.6% | 0.12% | +7.4% |
| Q4 2015 | $490,000 | +12.6% | 12,856 | -3.0% | 0.11% | +4.9% |
| Q3 2015 | $435,000 | -59.6% | 13,256 | -14.0% | 0.10% | -49.3% |
| Q2 2015 | $1,077,000 | -1.6% | 15,406 | -3.7% | 0.20% | -2.4% |
| Q1 2015 | $1,095,000 | -13.0% | 15,992 | -6.8% | 0.21% | -12.2% |
| Q4 2014 | $1,258,000 | -2.7% | 17,162 | -4.7% | 0.24% | -4.8% |
| Q3 2014 | $1,293,000 | -3.4% | 18,012 | -2.7% | 0.25% | +2.0% |
| Q2 2014 | $1,338,000 | -5.1% | 18,512 | -3.4% | 0.24% | -6.5% |
| Q1 2014 | $1,410,000 | +2.1% | 19,161 | -3.5% | 0.26% | -1.1% |
| Q4 2013 | $1,381,000 | +1.1% | 19,861 | -4.5% | 0.26% | -5.0% |
| Q3 2013 | $1,366,000 | -16.8% | 20,795 | -12.2% | 0.28% | -19.0% |
| Q2 2013 | $1,641,000 | – | 23,695 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |